clarithromycin has been researched along with sulfamethoxazole in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (6.45) | 18.7374 |
| 1990's | 4 (12.90) | 18.2507 |
| 2000's | 9 (29.03) | 29.6817 |
| 2010's | 13 (41.94) | 24.3611 |
| 2020's | 3 (9.68) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, BJ; Edwards, SW; Hart, CA; Martin, HM; Rhodes, JM; Roberts, CL; Subramanian, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Almayah, AA; Bolandnazar, Z; Ebrahimi, A; Ebrahimi, HP; Hadi, JS; Swadi, AG | 1 |
| Bailer, R; Bower, RR; Fernandes, PB; Gade, E; Hanson, CW; Hardy, D; McDonald, E; Ramer, N; Shipkowitz, N; Swanson, R | 1 |
| Kapell, KS; Kessler, HA; Segreti, J; Trenholme, GM | 1 |
| Hughes, WT; Killmar, JT; Oz, HS | 1 |
| Alder, J; Clement, JC; Hutch, T; Meulbroek, JA | 1 |
| Alder, J; Clement, J; Hernandez, L; Hui, YH; Marsh, K; Mitten, M; Shipkowitz, N | 1 |
| Bergmann, JS; Boulet, B; Brown, BA; Fahle, GA; Plaunt, M; Wallace, RJ; Wanger, A; Witebsky, FG; Woods, GL | 1 |
| Asencio Marchante, R; Lissen Otero, E | 1 |
| Carriere, KC; Jin, Y; Johnson, D; Marrie, T | 1 |
| Greenspan, DL; Hooton, TM; Jacobson, M; Slattery, JT; Trapnell, CB; Unadkat, JD; Winter, HR | 1 |
| Giger, W; Göbel, A; Joss, A; McArdell, CS; Thomsen, A | 1 |
| Gagnon, C; García-Ac, A; Ghosh, D; Lajeunesse, A; Sauvé, S; Segura, PA | 1 |
| Asmin, J; Escher, BI; Hollender, J; Kwon, JH; Steimen, I; Vermeirssen, EL | 1 |
| Goldstein, EJ; Lembo, G; Mandelbaum, B; Troum, O | 1 |
| Agüera, A; Fatta-Kassinos, D; Fernández-Ibáñez, P; García-Fernández, I; Karaolia, P; Malato, S; Michael, I | 1 |
| Alechaga, E; Boleda, MR; Galceran, MT; Moyano, E; Ventura, F | 1 |
| Matsumoto, T; Otsuka, K; Tomii, K | 1 |
| Shibayama, K; Tsutsui, A; Yahara, K | 1 |
| Aderemi, AO; Alves, LM; Hunter, C; Lemos, MFL; Novais, SC; Pahl, O | 1 |
| Hwang, SH; Jung, HJ; Kang, TW; Kim, K; Lee, KH; Na, TW | 1 |
| Ebinghaus, R; Gandrass, J; Kötke, D; Xie, Z | 1 |
| Giebułtowicz, J; Harnisz, M; Korzeniewska, E; Kucharski, D; Nałęcz-Jawecki, G; Płaza, G | 1 |
| Alvarenga, DJ; Campos, MMA; Carvalho, DT; Castro, LFD; Hawkes, JA; Leão, LPMO; Matias, LMF; Oliveira, LM; Raimundo, BVB; Santos, TD; Siqueira, FDS | 1 |
| Chiron, S; de Melo Costa Serge, N; Goetz, V; Li, C; Nogueira, RFP | 1 |
1 review(s) available for clarithromycin and sulfamethoxazole
| Article | Year |
|---|---|
Successful treatment of Mycobacterium terrae complex infection of the knee.
Topics: Anti-Bacterial Agents; Arthroscopy; Clarithromycin; Diagnosis, Differential; Drug Therapy, Combination; Humans; Joint Diseases; Knee Joint; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Treatment Outcome | 2012 |
1 trial(s) available for clarithromycin and sulfamethoxazole
| Article | Year |
|---|---|
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
Topics: Adult; Anti-Infective Agents; Area Under Curve; CD4 Lymphocyte Count; Clarithromycin; Drug Interactions; Female; Fluconazole; HIV Infections; HIV-1; Humans; Male; Middle Aged; Rifabutin; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
29 other study(ies) available for clarithromycin and sulfamethoxazole
| Article | Year |
|---|---|
Replication of Colonic Crohn's Disease Mucosal Escherichia coli Isolates within Macrophages and Their Susceptibility to Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cells, Cultured; Colon; Crohn Disease; Culture Media; Escherichia coli; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Monocytes; Mucous Membrane | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Metal-based biologically active azoles and β-lactams derived from sulfa drugs.
Topics: Anti-Bacterial Agents; Azoles; Bacteria; Bacterial Infections; beta-Lactams; Coordination Complexes; Humans; Ligands; Microbial Sensitivity Tests; Models, Molecular; Schiff Bases; Sulfamethoxazole; Sulfathiazole; Sulfathiazoles | 2016 |
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Drug Combinations; Drug Synergism; Erythromycin; Female; Guinea Pigs; Humans; Hydrogen-Ion Concentration; Injections, Subcutaneous; Kinetics; Legionella; Legionnaires' Disease; Male; Mice; Microbial Sensitivity Tests; Sulfamethoxazole | 1986 |
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Combinations; Erythromycin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Treatment of experimental Toxoplasma gondii infection by clarithromycin-based combination therapy with minocycline or pyrimethamine.
Topics: AIDS-Related Opportunistic Infections; Animals; Clarithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Mice; Minocycline; Pyrimethamine; Sulfamethoxazole; Toxoplasma; Toxoplasmosis, Animal | 1994 |
Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole.
Topics: Animals; Clarithromycin; Dexamethasone; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Male; Pentamidine; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Sulfamethoxazole; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Culture Media; Doxycycline; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Sulfamethoxazole; Tobramycin | 1999 |
[Secondary prevention of opportunistic infections in HIV-infected patients].
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antiprotozoal Agents; Antitubercular Agents; Antiviral Agents; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ethambutol; Ganciclovir; Humans; Leucovorin; Mycobacterium avium-intracellulare Infection; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Rifabutin; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis; Trimethoprim | 2001 |
Appropriate antibiotic utilization in seniors prior to hospitalization for community-acquired pneumonia is associated with decreased in-hospital mortality.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clarithromycin; Community-Acquired Infections; Comorbidity; Drug Prescriptions; Drug Utilization; Female; Hospital Mortality; Hospitalization; Humans; Male; Odds Ratio; Pneumonia; Preventive Health Services; Retrospective Studies; Sulfamethoxazole; Survival Rate; Trimethoprim | 2004 |
Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment.
Topics: Adsorption; Anti-Infective Agents; Azithromycin; Clarithromycin; Environmental Monitoring; Humans; Macrolides; Sewage; Sulfamethoxazole; Sulfonamides; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical | 2005 |
Determination of six anti-infectives in wastewater using tandem solid-phase extraction and liquid chromatography-tandem mass spectrometry.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Ofloxacin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water Pollutants, Chemical | 2007 |
The role of hydrodynamics, matrix and sampling duration in passive sampling of polar compounds with Empore SDB-RPS disks.
Topics: Carbamazepine; Clarithromycin; Environmental Monitoring; Estrogens; Pharmaceutical Preparations; Rivers; Sulfamethoxazole; Water Movements; Water Pollutants, Chemical; Yeasts | 2008 |
Reduction of clarithromycin and sulfamethoxazole-resistant Enterococcus by pilot-scale solar-driven Fenton oxidation.
Topics: Aliivibrio fischeri; Biological Assay; Chromatography, High Pressure Liquid; Clarithromycin; Disinfection; Drug Resistance, Bacterial; Enterococcus; Hydrogen Peroxide; Iron; Oxidation-Reduction; Sulfamethoxazole; Tandem Mass Spectrometry; Water Microbiology; Water Pollutants, Chemical; Water Purification | 2014 |
Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.
Topics: Azithromycin; Chromatography, Liquid; Clarithromycin; Drinking Water; Environmental Monitoring; Erythromycin; Ibuprofen; Pharmaceutical Preparations; Spain; Sulfamethoxazole; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2014 |
Mycobacterium fortuitum thoracic empyema: A case report and review of the literature.
Topics: Amikacin; Anti-Bacterial Agents; Chronic Disease; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Empyema, Pleural; Humans; Hypercapnia; Imipenem; Male; Middle Aged; Mycobacterium fortuitum; Noninvasive Ventilation; Sulfamethoxazole | 2015 |
Trends and patterns of national antimicrobial consumption in Japan from 2004 to 2016.
Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Clarithromycin; Drug Utilization; Fluoroquinolones; Humans; Infusions, Parenteral; Japan; Macrolides; Product Surveillance, Postmarketing; Sulfamethoxazole; World Health Organization | 2018 |
Oxidative stress responses and cellular energy allocation changes in microalgae following exposure to widely used human antibiotics.
Topics: Animals; Anti-Bacterial Agents; Catalase; Chlorophyta; Ciprofloxacin; Clarithromycin; Energy Metabolism; Environmental Exposure; Erythromycin; Humans; Lipid Peroxidation; Microalgae; Oxidative Stress; Sulfamethoxazole; Superoxide Dismutase; Water Pollutants, Chemical | 2018 |
Distribution and ecological risk of pharmaceuticals in surface water of the Yeongsan river, Republic of Korea.
Topics: Carbamazepine; Chromatography, Liquid; Clarithromycin; Ecosystem; Environmental Monitoring; Naproxen; Pharmaceutical Preparations; Republic of Korea; Risk Assessment; Rivers; Sulfamethoxazole; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2019 |
Prioritised pharmaceuticals in German estuaries and coastal waters: Occurrence and environmental risk assessment.
Topics: Aquatic Organisms; Baltic States; Chromatography, High Pressure Liquid; Clarithromycin; Ecotoxicology; Environmental Monitoring; Estuaries; Germany; Limit of Detection; Pharmaceutical Preparations; Risk Assessment; Seawater; Sulfamethoxazole; Water Pollutants, Chemical | 2019 |
Environmental Risk and Risk of Resistance Selection Due to Antimicrobials' Occurrence in Two Polish Wastewater Treatment Plants and Receiving Surface Water.
Topics: Anti-Infective Agents; Azithromycin; Chromatography, Liquid; Ciprofloxacin; Clarithromycin; Sewage; Sulfamethoxazole; Tandem Mass Spectrometry; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2020 |
Exploring how structural changes to new Licarin A derivatives effects their bioactive properties against rapid growing mycobacteria and biofilm formation.
Topics: Anti-Bacterial Agents; Biofilms; Clarithromycin; Lignans; Microbial Sensitivity Tests; Mycobacterium; Myristica; Nontuberculous Mycobacteria; Sulfamethoxazole | 2020 |
Peroxydisulfate activation by CuO pellets in a fixed-bed column, operating mode and assessments for antibiotics degradation and urban wastewater disinfection.
Topics: Amoxicillin; Anti-Bacterial Agents; Cephalexin; Clarithromycin; Copper; Disinfection; Escherichia coli; Ofloxacin; Oxidants; Oxides; Phenol; Sulfamethoxazole; Wastewater | 2022 |